Study on PFAS and fatty liver disease – women more affected than men
According to the study led by Professor Matej Orešič and Professor Tuulia Hyötyläinen, women are more affected than men when they are exposed to PFAs. A study from Örebro University shows how PFAS affect metabolism and lead to liver damage, so-called fatty liver disease.
“Exposure to environmental chemicals such as PFAS can exacerbate certain diseases and increase the risk of diabetes,” says Matej Orešič.
PFAS have consequently been identified as a cause of fatty liver disease. However, there is a knowledge gap in how these chemicals impact liver metabolism, which in turn is linked to the disease.
“We are able to show that PFAS cause changes in bile acids and we can demonstrate the link between bile acids and lipid and glucose metabolism. Our findings, therefore, provide an explanation for the underlying mechanism of already identified factors for the development of non-alcoholic fatty liver disease,” says Tuulia Hyötyläinen.
Recent Posts
-
Christel Sourander Successfully Defends Her Thesis
Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity and Read moreSeptember 9, 2025
-
Researchers at Åbo Akademi University Discover a New Molecular Switch Regulating Breast Cancer Progression
A research group led by our our affiliated group leader Professor Lea Sistonen at Åbo Read moreSeptember 4, 2025
-
Autumn 2025 Frontiers of Science seminars start soon
Frontiers of Science is a long-running seminar series, celebrating over 25 years of bringing internationally Read moreSeptember 3, 2025
-
The Elias Tillandz Prize to Turku Bioscience Researchers
The Elias Tillandz Prize for the Best Scientific Publication of 2024 was presented for two Read moreSeptember 2, 2025
-
Registration to FFGC Sequencing day is open!
Registration to FFGC Sequencing day is open! The event is organized by Finnish Functional Genomics Read moreAugust 27, 2025
-
Dr. Inna Starskaia received a three-year training award from Breakthrough T1D
Dr. Inna Starskaia has been awarded a prestigious three-year training award from Breakthrough T1D, the Read moreAugust 22, 2025